Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Special Correspondent

TN constitutes task force for mucormycosis

Amphotericin B, the drug used in the treatment of mucormycosis. Photograph used for representational purposes only (Source: The Hindu)

A Task Force Committee chaired by the Director of Medical Education (DME) has been constituted to advise the State government on issues related to mucormycosis, the invasive fungal disease being reported in patients recovering from COVID-19.

The committee, which comprises 12 members including medical experts drawn from a number of specialities from government and private hospitals, would advise the government on prevention and treatment of mucormycosis and update it on the latest translational research on mucormycosis.

While the DME is the chairman of the committee, the director of Regional Institute of Ophthalmology and Government Ophthalmic Hospital is the member secretary. The directors of Medical and Rural Health Services and Public Health and Preventive Medicines are among the members of the committee.

ENT specialists Mohan Kameswaran of Madras ENT Research Foundation and Babu Manohar of Apollo Hospitals, infectious diseases specialists Subramanian Swaminathan of Global Hospital and V. Ramasubramanian of Apollo Hospitals, Mohan Rajan of Rajan Eye Care, microbiologists Anupama Nithya of Sri Ramachandra Hospital and Balajee of Global Hospital, the heads of ENT and Microbiology departments of Madras Medical College are the other members of the task force.

The State government on May 20 declared mucormycosis as a notified disease under the Tamil Nadu Public Health Act, 1939.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.